Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nevro Corp (NVRO)

Nevro Corp (NVRO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,776,962
  • Shares Outstanding, K 31,007
  • Annual Sales, $ 387,290 K
  • Annual Income, $ -49,210 K
  • 60-Month Beta 0.38
  • Price/Sales 9.93
  • Price/Cash Flow N/A
  • Price/Book 18.86

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.68
  • Number of Estimates 8
  • High Estimate -0.36
  • Low Estimate -0.96
  • Prior Year -0.32
  • Growth Rate Est. (year over year) -112.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
111.18 +12.17%
on 01/14/20
126.93 -1.75%
on 01/22/20
+10.39 (+9.09%)
since 12/20/19
3-Month
82.19 +51.73%
on 10/30/19
126.93 -1.75%
on 01/22/20
+42.40 (+51.51%)
since 10/22/19
52-Week
41.25 +202.33%
on 02/22/19
126.93 -1.75%
on 01/22/20
+78.91 (+172.29%)
since 01/22/19

Most Recent Stories

More News
Nevro to Present New Clinical Evidence at the 23rd Annual North American Neuromodulation (NANS) Society Meeting

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations supporting...

NVRO : 124.71 (+2.38%)
Nevro Names Donald A. Middlebrook to Lead Clinical, Regulatory and Quality

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that Donald A. Middlebrook has been named...

NVRO : 124.71 (+2.38%)
Nevro Corp Up 36.9% Since SmarTrend Uptrend Call (NVRO)

SmarTrend identified an Uptrend for Nevro Corp (NYSE:NVRO) on October 28th, 2019 at $86.40. In approximately 3 months, Nevro Corp has returned 36.89% as of today's recent price of $118.27.

NVRO : 124.71 (+2.38%)
Nevro (NVRO) Gains Ground on Solid Preliminary Q4 Results

Higher revenues and upbeat 2020 worldwide revenue outlook benefit Nevro's (NVRO) preliminary Q4 results.

CERN : 75.52 (-0.38%)
NVRO : 124.71 (+2.38%)
DXCM : 235.54 (+1.69%)
HQY : 72.86 (+1.42%)
Look for Shares of Nevro Corp to Potentially Rebound after Yesterday's 1.12% Sell Off

Nevro Corp (NYSE:NVRO) traded in a range yesterday that spanned from a low of $111.18 to a high of $114.71. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $115.46...

NVRO : 124.71 (+2.38%)
Nevro Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenue

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced its preliminary unaudited revenue for...

NVRO : 124.71 (+2.38%)
Nevro Corp Set to Possibly Rebound After Yesterday's Selloff of 1.64%

Nevro Corp (NYSE:NVRO) traded in a range yesterday that spanned from a low of $115.87 to a high of $119.37. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $117.01...

NVRO : 124.71 (+2.38%)
Nevro to Host Investor Briefing at North American Neuromodulation Society (NANS) 2020 Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that it will host and webcast an investor...

NVRO : 124.71 (+2.38%)
Shares of NVRO Up 37.9% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Nevro Corp (NYSE:NVRO) on October 28th, 2019 at $86.40. In approximately 2 months, Nevro Corp has returned 37.92% as of today's recent price of $119.16.

NVRO : 124.71 (+2.38%)
Uptrend Call Working As Nevro Corp Stock Rises 33.3% (NVRO)

SmarTrend identified an Uptrend for Nevro Corp (NYSE:NVRO) on October 28th, 2019 at $86.40. In approximately 2 months, Nevro Corp has returned 33.26% as of today's recent price of $115.13.

NVRO : 124.71 (+2.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade NVRO with:

Business Summary

Nevro Corp. is a medical device company. It engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain. The Company provides pain relief to the customers suffering from low back pain and types of chronic pains. Nevro has developed and commercialized the Senza...

See More

Key Turning Points

2nd Resistance Point 129.16
1st Resistance Point 126.93
Last Price 124.71
1st Support Level 122.49
2nd Support Level 120.27

See More

52-Week High 126.93
Last Price 124.71
Fibonacci 61.8% 94.20
Fibonacci 50% 84.09
Fibonacci 38.2% 73.98
52-Week Low 41.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar